
Corporate Event Manager
MCI USA
District of Columbia, USA (Remote)
Bedford, MA (Remote)
Posted 3 days ago
Own and lead Ocular’s corporate communications program, shaping reputation, executive messaging, media relations, and strategic communications across the organization.
Ocular Therapeutix, Inc. is a biopharmaceutical company committed to redefining the retina experience across drug development, treatment, and outcomes. AXPAXLITM (also known as OTX-TKI), an investigational axitinib hydrogel administered by intravitreal injection, is Ocular’s leading investigational candidate for retinal disease, based on its proprietary ELUTYXTM technology. AXPAXLI is currently in Phase 3 clinical trials for wet age-related macular degeneration (wet AMD) and has potential applications across other retinal diseases such as non-proliferative diabetic retinopathy (NPDR) and diabetic macular edema (DME).
Posted range
$320K/yr – $345K/yr
Taken straight from the job posting.

MCI USA
District of Columbia, USA (Remote)

The Business of HLTH Podcast
District of Columbia, USA (Remote)

Amylyx Pharmaceuticals
Cambridge, MA (Remote)

H&R Block
USA (Remote)
Flix SE
Dallas, TX (Remote)